ISO 20387:2018: The Key to Quality Biobanking
In the last two decades, clinical research has grown exponentially; therefore, the demand for high-quality biological samples has increased, not to mention the last two years. The most recent pandemic has accelerated the need to optimize and automate processes...
Digitization: Enabling Biobanks Navigate Through Regulatory Challenges
Over the past two decades, there has been an increased need for collecting, curating, storing, and distributing biological specimens to gain specific information into the genetic makeup of diseases . This has sparked the demand for biobanking.
Genetic and biomedical...
Are You Just Seeking Approval: Digging Deep into Biobanking Ethics
This is going to be a bit deep, but bear with me...
Biobankers are interested in ethics. To manage our tissue collections we need either approval by an ‘Ethics Board’ or we operate as part of a regulatory system used...
The Need for Patient-Pushed, Real-World Data on Neurodegenerative Diseases
Neurodegenerative diseases, is a collective term for a group of disorders characterized by the progressive neurodegeneration of brain cells, leading to dysfunction(s) and abnormal structure(s) in the central and/or peripheral nervous systems. One of the main causes of neurodegeneration...
Identification of Factors that Influence Willingness of Native Americans to Donate Biospecimens: Increasing Equity...
American Indian and Alaska Native (AI/AN) people have a long history of lower life expectancy and higher disease burden compared with the general US populationand are more likely to suffer from chronic diseases1. Addressing AI/AN health inequities is a...
How Biobanks Can Support Personalized Medicine
Biobanks should be an integral part of a comprehensive research platform, not exclusively viewed as a service provider or freezer farm managed with excel sheets. For biobanks to be be viewed as a contributing partner and one that can...
Observations On Recruitment For The Mayo Clinic Biobank
In order to draw generalizable conclusions, it is important
that cohort studies represent the population of interest faithfully. Against
this backdrop it has been noted that not all individuals are equally willing to
participate in biobank related studies. Factors associated with willingness...
New Trends in Biobanking Based on Main International Events in 2019
What were the most attractive biobanking ideas in 2019?
ISBER (International Society for Biological and Environmental Repositories) and ESBB (European, Middle Easter and African Society for Biopreservation and Biobanking) are the two biggest world leaders in the biobanking area. Every...
Dynamic Consent In Biobanking Using Dwarna – A Blockchain Solution
A research team with senior author Jean-Paul Ebejer from the Centre for Molecular Medicine and Biobanking at the University of Malta has created a blockchain solution for dynamic consent in biobanking called Dwarna. They published their solution in...
Finding The Right Balance – Return of Results to Biobank Participants
In the course of research based on a biobank population occasionally a condition may be revealed in a particular individual, which was not known before the study, and for which the study was not explicitly designed. This is known...
